How much funding has GC Therapeutics raised?

GC Therapeutics has raised $65.0M in total funding, most recently a Series A round.

When was GC Therapeutics founded?

GC Therapeutics was founded in 2019.

Where is GC Therapeutics headquartered?

GC Therapeutics is headquartered in Cambridge, Massachusetts, United States.

What industry is GC Therapeutics in?

GC Therapeutics operates in Healthcare, Biotech.

How many employees does GC Therapeutics have?

GC Therapeutics has 11-50 employees.

GC Therapeutics

Q: Who are GC Therapeutics's investors?

GC Therapeutics's investors include Cormorant Asset Management, Andreessen Horowitz.

Cambridge, United States · Founded 2019 · $65.0M raised

Healthcare

Biotech

Headquarters: Cambridge, Massachusetts
Employees: 11–50
Founded: 2019
Business Model: B2B

Website: gc-tx.com
Total Funding: $65.0M
Last Round: $65.0M Series ASep 2024
Rounds: 1

About

GC Therapeutics (GCTx) is a Cambridge, MA-based biopharmaceutical company using synthetic biology and its proprietary TFome iPSC programming platform to convert patient-derived stem cells into therapeutic cell types with best-in-class efficiency. Founded by scientists from George Church's lab at Harvard, GCTx is developing allogeneic cell therapies for gastrointestinal, neurological, and immunological diseases.

Summary

GC Therapeutics is a Healthcare company based in Cambridge, United States, founded in 2019. It has raised $65.0M in total across 1 round, most recently a $65.0M Series A round in Sep 2024. Investors include Cormorant Asset Management and Andreessen Horowitz.

LinkedIn X (Twitter)